Medicamen Biotech is currently trading at Rs. 777.00, up by 5.65 points or 0.73% from its previous closing of Rs. 771.35 on the BSE.
The scrip opened at Rs. 789.90 and has touched a high and low of Rs. 799.05 and Rs. 754.40 respectively. So far 8398 shares were traded on the counter.
The BSE group ‘B’ stock of face value Rs. 10 has touched a 52 week high of Rs. 1023.25 on 27-Dec-2021 and a 52 week low of Rs. 495.55 on 22-Oct-2021.
Last one week high and low of the scrip stood at Rs. 787.40 and Rs. 683.10 respectively. The current market cap of the company is Rs. 949.23 crore.
The promoters holding in the company stood at 43.60%, while Institutions and Non-Institutions held 0.35% and 56.06% respectively.
Medicamen Biotech is planning to raise funds by way of issue of one or more instruments including equity shares/ convertible securities or warrants on preferential basis at such price as may be determined in accordance with the SEBI. The meeting of the board of directors is scheduled to be held on August 01, 2022 to consider the same.
Medicamen Biotech is engaged in manufacturing and marketing of pharmaceutical formulations in overseas and domestic markets.